Influence of drugs on myocardial iodine-123 metaiodobenzylguanidine uptake in rabbit myocardium

European Journal of Nuclear Medicine

Volumn 27, Issue 3, 2000, Pages 340-345

  Mayer, Sebastian ^a   Karanikas, Georgios ^a   Rodrigues, Margarida ^a   Sinzinger, Helmut ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Drug influence; Iodine 123 metaiodobenzylguanidine; Myocardial uptake; Rabbit myocardium; Uptake mechanism

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CLOMIPRAMINE; CLONIDINE; DOPAMINE; ENALAPRIL; HALOPERIDOL; LABETALOL; LEVOMEPROMAZINE; METOPROLOL; PERTECHNETIC ACID TC 99M; SOTALOL; TRAZODONE; URAPIDIL; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DRUG UPTAKE; HEART; HEART MUSCLE; NONHUMAN; RABBIT; TEMPERATURE; TIME;

EID: 0034068214     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050043     Document Type: Article

References (28)

1. 131I-iodo-benzylguanidine. J Nucl Med 1980; 21: 349-353.
2. Sisson JC, Frager MS, Valk TW, Gross MD, Swanson DP, Wieland DM, Tobes MC, Beierwalters WH, Thomson NW. Scintigraphic localisation of pheochromocytoma. N Engl J Med 1981; 305: 12-17.
3. Hoefnagel CA. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumors. Eur J Nucl Med 1994; 21: 561-581.
4. Tobes MC, Jaques S Jr, Wieland DM, Sisson JC. Effect of uptake-one inhibitors on the uptake of norepinephrine and meta-iodobenzylguanidine. J Nucl Med 1985; 26: 897-907.
5. Gasnier B, Roisin MP, Scherman D, Coornaert S, Desplanches G, Henry JP. Uptake of meta-iodobenzylguanidine by bovine chromaffin granule membranes. Mol Pharmacol 1986; 29: 275-280.
6. Jaques S Jr, Tobes MC, Sisson JC. Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one. Cancer Res 1987; 47: 3920-3928.
7. Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jaques S Jr. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987; 28: 1620-1624.
8. Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, Beierwalters WH. Myocardial imaging in man with I-123-metaiodobenzylguanidine. J Nucl Med 1981; 22: 129-132.
9. Hartikainen J, Kuikka J, Maentissary M, Laensimies E, Pyoeraelae K. Sympathetic reinnervation after acute myocardial infarction. Am J Cardiol 1996; 77:5-7.
10. Sakata K, Miura F, Sugino H, Saegusa T, Shirotani M, Yoshida H, Hoshino T, Kurata C. Assessment of sympathetic nerve activity in vasospastic angina: analysis of iodine 123-labeled metaiodobenzylguanidine scintigraphy. Am Heart J 1997; 4: 484-489.
11. Nagaoka H, Iizuka T, Kubota S, Suzuki T, Inoue T, Endo K, Nagai R. Depressed contractile response to exercise in diabetic patients in the absence of cardiovascular disease: relationship to adrenergic cardiac denervation. Nucl Med Commun 1997; 18: 761-770.
12. Morimoto S, Terada K Keira N, Satoda M, Inoue K, Tatsukawa H, Katoh S, Ida K, Sugihara H, Takeda K, Nakagawa M. Investigation of the relationship between regression of hypertensive cardiac hypertrophy and improvement of cardiac sympathetic nervous function using iodine-123-metaiodobenzylguanidine myocardial imaging. Eur J Nucl Med 1996; 23: 756-761.
13. 123I-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure. Heart 1996; 76: 218-222.
14. 123I-MIBG by polar map in patients with dilated cardiomyopathy. Nucl Med Commun 18: 219-229.
15. 123I-metaiodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy. Am Heart J 1990; 119: 1329-1337.
16. 123I-meta-iodobenzylguanidine in isolated rat heart. Nucl Med Biol 1995; 22: 1-12.
17. Jaques S Jr, Tobes MC, Sisson JC. Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one. Cancer Res 1987; 47: 3920-3928.
18. Iversen LL, Salt PJ, Wilson HA. Inhibition of catecholamine uptake in the isolated rat heart by haloalkylamines related to phenoxybenzamine. Br J Pharmacol 1972; 46: 647-657.
19. Khafagi FA, Shapiro B, Fig LM, Malette S, Sisson JC. Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. J Nucl Med 1989; 30: 481-489.
20. 123I-MIBG) [abstract]. Eur J Nucl Med 1988; 14: 259.
21. Sherman P, Fisher S, Wieland D, Sisson J. Over the counter drugs block heart accumulation of MIBG [abstract]. J Nucl Med 1985; 26: P35.
22. Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 1992; 13: 513-521.
23. Jaques S Jr, Tobes MC, Sisson JC. Effect of calcium (Ca) channel blockers on acetylcholine (Ach) stimulated and basal release of meta-iodobenzylguanidine (MIBG) and norepinephrine (NE) in cultured bovine adrenomedullary cells [abstract]. J Nucl Med 1987; 28: 639-640.
24. Dae MW, De Marco T, Botvinick EH, O'Connell JW, Hattner RS, Huberty JP, Yuen-Green MS. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts - implications for clinical studies. J Nucl Med 1992; 33: 1444-1450.
25. Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H. ACE-inhibition reduces cardiac-123-MIBG release in heart failure. J Nucl Med 1997; 38: 1085-1089.
26. Sakata K, Shirotani M, Yoshida H, Kurata C. Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension. J Am Coll Cardiol 1998; 32: 438-443.
27. Huguet F, Fagret D, Caillet M, Piriou A, Besnard JC, Guilloteau D. Interaction of metaiodobenzylguanidine with cardioactive drugs: an in vitro study. Eur J Nucl Med 1996; 23: 546-549.
28. 131I-meta-iodobenzylguanidine scintigraphy of neuroblastomas. Semin Nucl Med 1985; 2: 154-160.